A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study

References

• ANTHONY, M. L., GARTLAND, K. P R., BEDDELL, C. R., LINDON, J. C. and NICHOLSON, J. K. 1992, Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage. Archives of Toxicology, 66, 525–537.
   Google Scholar
• BECKWITH-HALL, B. M., NICHOLSON, J. K., NICHOLLS, A. W., FOXALL, P J. D., LINDON, J. C., CONNOR, S. C., ABDI, M., CONNELLY, J. and HOLMES, E. 1998, Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chemical Research in Toxicology, 11,260–272.
   Google Scholar
• BRINDLEY, D. N. and BOWLEY, M. 1975, Drugs affecting the synthesis of glycerides and phospholipids in rat liver, the effects of clofibrate, halofenate, fenfluramine, amphetamine, cinchocaine, chloropromazine, demethylimipramine, mepyramine and some of their derivatives. Biochemical Journal, 148(3), 461–469.
   PubMed Web of Science ®Google Scholar
• DAVIS, B. A., DURDEN, D. A. and BOULTON, A. A. 1982, Plasma concentrations of p- and m-hydroxyphenylacetic acid and phenylacetic acid in humans. Gas chromatographic-high resolution mass spectrometric analysis. Journal of Chromatography, 230, 219–230.
   PubMed Web of Science ®Google Scholar
• DAVIS, B. A., KENNEDY, S. H., D'SouzA, J., DURDEN, D. A., GOLDBLOOM, D. S. and BOULTON, A. A. 1994, Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behaviour and mood rating scores in brofaromine-treated woman with bulimia nervosa. Journal of Psychiatry and Neuroscience, 19, 282–288.
   Google Scholar
• DUNNETT, R. E. 1964, New tables for multiple comparisons with a control. Biometrics, 20, 482–492.
   Web of Science ®Google Scholar
• DE DUVE, C., DE BARSY, T., POOLE, B., TROUET, A., TULKENS, P and VAN HOOF, E 1974, Lysosomotropic agents. Biochemical Pharmacology, 23, 2495–2531.
   Google Scholar
• GOODWIN, B. L., RUTHVEN, C. R. J. and SANDLER, M. 1994, Gut flora and the origin of some urinary aromatic phenolic compounds. Biochemical Pharmacology, 47, 2294–2297.
   Google Scholar
• GRAY, J. A., NICHOLSON, J. K. and TIMBRELL, J. A. 1986, Creatinuria as an early indicator of cadmium induced testicular damage. Human Toxicology, 5, 402–403.
   Google Scholar
• GRAY, J. A., NICHOLSON, J. K., CREASY, D. M. and TIMBRELL, J. A. 1990, Studies on the relationship between testicular toxicity and urinary and plasma creatine concentration. Archives of Toxicology, 64, 443–450.
   PubMed Web of Science ®Google Scholar
• HALLIWELL, W. H. 1997, Cationic amphiphilic drug-induced phospholipidosis. Toxicologic Pathology, 25(1), 53–60.
   PubMed Web of Science ®Google Scholar
• HOLLINGER, M. A. 1993, Drug-induced lung toxicity. Journal of the American College of Toxicology, 12, 31–47.
   Google Scholar
• HOLMES, E, BONNER, E W., GARTLAND, K. P R. and NICHOLSON, J. K. 1990, Proton NMR monitoring of the onset and recovery of experimental renal damage. Journal of Pharmaceutical and Biomedical Analysis, 8, 959–962.
   Google Scholar
• HOLMES, E., NICHOLLS, A. W, LINDON, J. C., RAMOS, S., SPRAUL, M, NEIDIG, P, CONNOR, S. C., CONNELLY, J., DAMMENT, S.J.P., HASELDEN, J.N. and NICHOLSON, J.K. 1998a, Development of a model for classification of toxin-induced lesion using 1H NiVIR spectroscopy of urine combined with pattern-recognition. NMR in Biomedicine, 11, 235–244.
   PubMed Web of Science ®Google Scholar
• HOLMES, E., NICHOLSON, J. K., NICHOLLS, A. W., LINDON, J. C., CONNOR, S. C., POLLEY, S. and CONNELLY, J. 1998b, The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemometrics and Intelligent Laboratory Systems, 44, 245–255.
   Web of Science ®Google Scholar
• HOLLINGER, M. A. 1993, Drug-induced lung toxicity. Journal of the American College of Toxicology, 12, 31–47.
   Google Scholar
• Hook, G. E. R. 1991, Alveolar proteinosis and phospholipidoses of the lungs. Toxicologic Pathology, 19, 482–513.
   PubMed Web of Science ®Google Scholar
• JONES, A. R. 1982, Some observations on the urinary excretions of glycine conjugates by laboratory animals. Xenobiotica, 12(6), 387–395.
   PubMed Web of Science ®Google Scholar
• KAROUM, E, POTKIN S., CHUANG, L. W., MURPHY, D. L., LIEBOWITZ, M. R. and WYATT, R.J . 1984, Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man. Biological Psychiatry, 19, 165–178.
   Google Scholar
• KODAVANTI, U. P and MEHENDALE, H. M. 1990, Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacological Reviews, 42(4), 327–354.
   PubMed Web of Science ®Google Scholar
• KODAVANTI, U. P, LOCKARD, V. G. and MEHENDALE, H. M. 1990, In Vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. Journal of Biochemical Toxicology, 5, 245–251. LEHNINGER, A. L., NELSON, D. L. and Cox, M. M. 1993, Principles of Biochemistry (New York: Worth Publishers).
   Google Scholar
• LINDON, J. C., NICHOLSON, J. K. and EVERETT, J. R. 1999, NMR spectroscopy of biofluids. Annual Reports on NMR Spectroscopy, 38, 1–88.
   Web of Science ®Google Scholar
• LULLMANN, H., LULLMANN-RAUCH, R. and WASSERMANN, 0. 1975, Drug induced phospholipidosis. CRC Critical Reviews in Toxicology, 2, 185–218.
   Google Scholar
• NICHOLSON, J. K. and WILSON, I. D. 1987, High-resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development. Progress in Drug Research, 31, 427–429.
   PubMedGoogle Scholar
• NICHOLSON, J. K. and WILSON, I. D. 1989, High resolution proton magnetic resonance spectroscopy of biofluids. Progress in NMR Spectroscopy, 21, 449–501.
   Web of Science ®Google Scholar
• NICHOLSON, J. K., HIGHAM, D. P., TIMBRELL, J. A. and SADLER, P J. 1989, Quantitative high-resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Molecular Pharmacology, 36, 398–404.
   PubMed Web of Science ®Google Scholar
• NICHOLSON, J. K., FOXALL, P J. D., SPRAUL, M., FARRANT, R. D. and LINDON J. C. 1995, 750 MHz 1H and 1H-13C-NMR spectroscopy of human blood plasma. Analytical Chemistry, 67, 793–811.
   Google Scholar
• NICHOLSON, J. K., LINDON, J. C. and HOLMES, E. 1999, `Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29(11), 1181–1189.
   PubMed Web of Science ®Google Scholar
• REASOR, M. J., OGLE, C. L., WALKER, E. R. and KACEW, S. 1988, Amioadrone-induced phospholipidosis in rat alveolar macrophages. American Review of Respiratory Disease, 137, 510–518.
   PubMed Web of Science ®Google Scholar
• SABELLI, H. C., FAWCETT, J., GUSOVSKY, E, JAVAID, J., EDWARDS, J. and JEFFRIESS, H. 1983, Urinary phenylacetate: a diagnostic test for depression? Science, 20, 1187–1188.
   Google Scholar
• SANINS, S. M., NICHOLSON, J. K., ELCOMBE, C. and TIMBRELL, J. A. 1990, Hepatotoxin-induced hypertaurinuria: a proton NMR study. Archives of Toxicology, 64, 407–411.
   PubMed Web of Science ®Google Scholar
• STAYER, L. 1988, Biochemistry (New York: W.H. Freeman and Co).
   Google Scholar
• WATERFIELD, C. J., TURTON, J. A., SCALES, M. D. C. and TIMBRELL, J. A. 1993a, Investigations into the effects of various hepatotoxic compounds on urinary and liver levels of taurine in rats. Archives of Toxicology, 67, 244–254.
   Google Scholar
• WATERFIELD, C. J., TURTON, J. A., SCALES, M. D. C. and TIMBRELL, J. A. 1993b, Effects of various non-hepatotoxic compounds on urinary and liver levels of taurine in rats. Archives of Toxicology, 67, 538–546.
   Google Scholar